Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Evaluate historical worst drawdowns for index funds and translate insights into practical risk controls and withdrawal planning.
14,434 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
PIPPIN tumbled 45% in 24 hours, shaving roughly $200 million off its market cap as leveraged bets collapsed and trade...
NVIDIA signals a coming AI infrastructure wave, projecting demand that could exceed current forecasts and testing tal...
IonQ has surged nearly 200% over five years as quantum computing gains attention. This guide breaks down whether late...
The U.S.-led airstrike on Iran sent markets into a tailspin, with oil surging and stock indexes dropping. As policyma...
Considering international real estate for income? This article breaks down HAUZ and VNQ, showing how they differ, wha...
Oil prices climb as inflation concerns linger, prompting the Fed to hold rates steady for now. The impact rising fuel...
Meta Platforms is ending Horizon Worlds as a standalone VR social platform and redirecting capital to AI infrastructu...
The SEC is exploring a proposal that could let U.S. public companies report semiannually instead of quarterly, prompt...
Coinbase stock stalls $200 after a 14% surge, with traders watching volume and regulatory headlines for the next move...
As AI workloads surge, hyperscalers turn to ASICs to cut costs. This deep dive compares Broadcom and Marvell, explain...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...